Bank of America
PBM icon

Bank of America’s Psyence Biomedical PBM Stock Holding History

Bank of America’s Portfolio PBM Stock Details PBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-535
Closed -$2.52K – 6962
2025
Q4 		$2.52K Buy
535
+1
+0.2% +$15 ﹤0.01% 6375
2025
Q3 		$10.7K Hold
534
– – ﹤0.01% 7191
2025
Q2 		$17.8K Buy
+534
New +$14.8K ﹤0.01% 7081

Other funds holding PBM

PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

Bank of America's PBM Position: Q1 2026 in Review

Bank of America sold out of Psyence Biomedical (PBM) in Q1 2026, closing a stake of 535 shares — an estimated $2.52K sold.

Bank of America first reported a position in PBM in Q2 2025 and held it in 3 quarters. The position peaked at $17.8K in Q2 2025. 2 funds tracked by Wall St. Rank hold PBM as of Q1 2026.

  • Bank of America reported no remaining Psyence Biomedical position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 535 Psyence Biomedical shares in Q1 2026, an estimated $2.52K.
  • Bank of America first reported a position in Psyence Biomedical in Q2 2025 and held it in 3 quarters.
  • Bank of America's Psyence Biomedical position peaked at $17.8K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Psyence Biomedical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.